Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 3
Submit an article Journal homepage
210
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

A common ancestral DNMT3A-mutated preleukemic clone giving rise to AML and MDS in an adolescent girl

Gudrun GöhringInstitute of Human Genetics, Hannover Medical School, Hannover, Germany; Correspondence[email protected]
,
Kathrin ThomayInstitute of Human Genetics, Hannover Medical School, Hannover, Germany;
,
Gunnar SchmidtInstitute of Human Genetics, Hannover Medical School, Hannover, Germany;
,
Tim RippergerInstitute of Human Genetics, Hannover Medical School, Hannover, Germany;
,
Michael XuInstitute of Human Genetics, Hannover Medical School, Hannover, Germany; ;Manitoba Institute of Cell Biology, CancerCare Manitoba, Winnipeg, Canada;
,
Nicole WittnerInstitute of Human Genetics, Hannover Medical School, Hannover, Germany;
,
Mwe Mwe ChaoDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany;
,
Irith BaumannDepartment of Pathology, Clinical Center, Böblingen, Germany;
,
Marena NiewischDivision of Pediatric Hematology and Oncology, Department of Pediatrics, University Medical Center Freiburg, Freiburg, Germany;
,
Dirk ReinhardtClinic for Pediatrics III, University Hospital Essen, Essen, Germany;
,
Thomas KlingebielHospital for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany;
,
Felicitas TholDepartment of Hematology, Hemostasis, Oncology and SCT, Hannover Medical School, Hannover, Germany
,
Brigitte SchlegelbergerInstitute of Human Genetics, Hannover Medical School, Hannover, Germany;
&
Charlotte M. NiemeyerDivision of Pediatric Hematology and Oncology, Department of Pediatrics, University Medical Center Freiburg, Freiburg, Germany;
show all
Pages 718-721 | Received 10 Jun 2016, Accepted 22 Jun 2016, Published online: 28 Nov 2016

References

  • Ley TJ, Ding L, Walter MJ, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med. 2010;363:2424–2433.
  • Thol F, Damm F, Ludeking A, et al. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol. 2011;29:2889–2896.
  • Ho PA, Kutny MA, Alonzo TA, et al. Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011;57:204–209.
  • Juhl-Christensen C, Ommen HB, Aggerholm A, et al. Genetic and epigenetic similarities and differences between childhood and adult AML. Pediatr Blood Cancer. 2012;58:525–531.
  • Zwaan CM, Kolb EA, Reinhardt D, et al. Collaborative efforts driving progress in pediatric acute myeloid leukemia. J Clin Oncol. 2015;33:2949–2962.
  • Shlush LI, Zandi S, Mitchell A, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506:328–333.
  • Ploen GG, Nederby L, Guldberg P, et al. Persistence of DNMT3A mutations at long-term remission in adult patients with AML. Br J Haematol. 2014;167:478–486.
  • Challen GA, Sun D, Jeong M, et al. DNMT3A is essential for hematopoietic stem cell differentiation. Nat Genet. 2012;44:23–31.
  • Mayle A, Yang L, Rodriguez B, et al. DNMT3A loss predisposes murine hematopoietic stem cells to malignant transformation. Blood. 2015;125:629–638.
  • Genovese G, Kahler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371:2477–2487.
  • Kozyra E, Hirabayashi S, Pastor Loyola VB, et al. Clonal mutational landscape of childhood myelodysplastic syndromes. Paper presented at: Annual Meeting of the American Society of Hematology; December 2015; Orlando.
  • Klimek VM, Tray NJ. Therapy-related myeloid neoplasms: what's in a name? Curr Opin Hematol. 2016;23:161–166.
  • Strahm B, Nollke P, Zecca M, et al. Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia. 2011;25:455–462.
  • Araki D, Wood BL, Othus M, et al. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: time to move toward a minimal residual disease-based definition of complete remission? J Clin Oncol. 2016;34:329–336.
  • Hou HA, Kuo YY, Liu CY, et al. DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications. Blood. 2012;119:559–568.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.